Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00232206
Status:
TERMINATED
Last Update Posted:
2011-05-18
First Post:
2005-09-30
Brief Title:
Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer
Sponsor:
Providence Health Services
Organization:
Providence Health Services
Organization Data
Organization:
Providence Health Services
Class:
OTHER
Study ID:
PPMC-EACRI-IRB-05-032
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Providence Health Services
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Sanofi | INDUSTRY |
| Providence Cancer Center Earle A Chiles Research Institute | OTHER |